155 related articles for article (PubMed ID: 15212640)
1. Prediction of recurrence of nonfunctioning pituitary tumours by loss of heterozygosity analysis.
Buch HN; Raskauskiene D; Bahar A; Bicknell EJ; Farrell WE; Clayton RN
Clin Endocrinol (Oxf); 2004 Jul; 61(1):19-25. PubMed ID: 15212640
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
[TBL] [Abstract][Full Text] [Related]
3. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
4. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite analysis of breast carcinoma and corresponding local recurrences.
Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF
J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878
[TBL] [Abstract][Full Text] [Related]
6. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
[TBL] [Abstract][Full Text] [Related]
7. Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins.
Clayton RN; Pfeifer M; Atkinson AB; Belchetz P; Wass JA; Kyrodimou E; Vanderpump M; Simpson D; Bicknell J; Farrell WE
Clin Cancer Res; 2000 Oct; 6(10):3973-82. PubMed ID: 11051246
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
9. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
Li S; Wang H; Zhang C
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
[TBL] [Abstract][Full Text] [Related]
10. Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma.
Lu T; Hano H
Liver Int; 2007 Aug; 27(6):782-90. PubMed ID: 17617121
[TBL] [Abstract][Full Text] [Related]
11. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM
J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y
Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 14q LOH in localized clear cell renal cell carcinoma.
Mitsumori K; Kittleson JM; Itoh N; Delahunt B; Heathcott RW; Stewart JH; McCredie MR; Reeve AE
J Pathol; 2002 Sep; 198(1):110-4. PubMed ID: 12210070
[TBL] [Abstract][Full Text] [Related]
14. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients.
Petursdottir TE; Hafsteinsdottir SH; Jonasson JG; Moller PH; Thorsteinsdottir U; Huiping C; Egilsson V; Ingvarsson S
Anticancer Res; 2002; 22(6A):3205-12. PubMed ID: 12530066
[TBL] [Abstract][Full Text] [Related]
16. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
Xu XF; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
[TBL] [Abstract][Full Text] [Related]
17. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?
Szukała K; Sowińska A; Wierzbicka M; Biczysko W; Szyfter W; Szyfter K
Mutat Res; 2006 Aug; 600(1-2):67-76. PubMed ID: 16814812
[TBL] [Abstract][Full Text] [Related]
18. High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy.
Valeri A; Fromont G; Sakr W; Azzouzi R; Dey J; Chantrel-Groussard K; Latil A; Berthon P; Cussenot O; Pontes JE; Cher ML
Urol Oncol; 2005; 23(2):87-92. PubMed ID: 15869992
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery.
Lee DJ; Maseyesva B; Westra W; Long D; Niparko JK; Califano J
Otol Neurotol; 2006 Feb; 27(2):213-9. PubMed ID: 16436992
[TBL] [Abstract][Full Text] [Related]
20. Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA.
Gazvoda B; Juvan R; Zupanic-Pajnic I; Repse S; Ferlan-Marolt K; Balazic J; Komel R
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1082-9. PubMed ID: 17998833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
